GRI Bio, Inc.
GRI · NASDAQ
7/31/2025 | 4/30/2025 | 1/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | – |
| - Cash | $0 | $0 | $0 | – |
| + Debt | $0 | $0 | $0 | – |
| Enterprise Value | -$0 | -$0 | -$0 | – |
| Revenue | $0 | $0 | – | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | -$0 | $0 | – | -$0 |
| % Margin | – | 48.4% | – | – |
| EBITDA | -$0 | -$0 | – | -$0 |
| % Margin | – | -13.5% | – | – |
| Net Income | -$0 | -$0 | – | -$0 |
| % Margin | – | -13.5% | – | – |
| EPS Diluted | -1.31 | -5.8 | – | -7.86 |
| % Growth | 77.4% | – | – | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | – |
| Capital Expenditures | $0 | -$0 | $0 | – |
| Free Cash Flow | -$0 | -$0 | -$0 | – |